stella
beta
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires — Stella
Home
/
Systemic Lupus Erythematosus (Sle)
/
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
View on ClinicalTrials.gov
Recruiting
Back to Systemic Lupus Erythematosus (Sle) trials
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Trial locations
(1 site)
United States
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland